Gynecology and Pelvic Medicine《妇科与盆腔医学》（ISSN 2617-4499）是由AME出版社与四川大学华西第二医院-华西妇产儿童医院共同合作创办的一本国际同行评审期刊。由赵霞教授担任杂志主编，牛晓宇教授担任杂志执行主编，邀请一众国内外著名学者担任编委。该期刊专注于妇科与盆腔医学领域的基础、转化与临床研究，涵盖领域内包括妇科肿瘤、盆腔医学、良性妇科疾病等各方面内容，致力于促进中外妇科与盆腔医学的学术交流，为全球学者提供一个妇产科学领域国际学术交流平台。
《妇科与盆底医学（英文）》
（Gynecology and Pelvic Medicine）作者指南
【官网信息】
Guidelines for Authors
Thank you for your interest in Gynecology and Pelvic Medicine (ISSN 2617-4499; Gynecol Pelvic Med; GPM). GPM adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE) (1), and the Cope of Conduct and Best Practice Guidelines for Journal Editors (2), issued by the Committee on Publication Ethics (COPE). Please refer to the following guidelines to help you prepare your manuscript. Feel free to contact the editorial office by email (gpm@amegroups.com) should you have any questions. To ensure a swift peer review and publication process, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision at preliminary review.
1. ABOUT THE JOURNAL
Gynecology and Pelvic Medicine (ISSN 2617-4499; Gynecol Pelvic Med; GPM) is an international peer-reviewed, open-access journal covering various aspects in the gynecology and pelvic medicine, including gynecological oncology (with focus on ovarian cancer and cervical carcinoma), pelvic medicine (with focus on urinary incontinence, fecal incontinence, voiding dysfunction, pelvic organ prolapses, pelvic pain, urinary tract infections, and interstitial cystitis), as well as benign gynecological disease (including infection, endometriosis, abnormality, endocrinology, etc). It welcomes publications relevant to diagnosis and prevention, surgery, medical oncology, radiation medicine, pathology, basic cancer research, epidemiological and translational studies in the field.
2. MANUSCRIPT CATEGORIES
2.1 Original Article
Word limit: there is no fixed word limit for research articles, but authors must use the most concise language possible, as well as succinct, structured sentences. The word count for the main text (excluding the abstract, references, tables, boxes, or figures) should be provided when the manuscript is submitted.
Abstract: Structured (usually into four paragraphs with the following subheadings: Background, Methods, Results, and Conclusions, unless specified otherwise in the reporting checklists), 200-350 words max. No abbreviations.
Key words: 3~5.
References: No limit.
Figures/Tables: No limit, but 10 figures are deemed sufficient.
Description: Original articles should take the following format: Introduction, Methods, Results, Discussion and/or Conclusions. Original articles must have originality and clinical impact.
Original articles should include a section describing the contribution made by each author to the manuscript. See the “3.4 Author Contributions” sections for details.
If a submitted article includes any data that are not publicly available, the authors are required to fill in a data-sharing statement form, which should be submitted along with their manuscript. If the article is accepted for publication, the Data Availability Statement (form) will be published online alongside the article. See the “3.7.2 Data Sharing Statement” section for details.
When a manuscript documents any experiment(s) involving human subjects or animals, the authors must indicate an ethical statement both in the methods section and the footnote. See the “3.7.5 Ethical Statement” section for details.
Please note that systematic review with meta-analysis will be categorized as Original Article.
2.1.1 Reporting Checklist
Original Articles should be prepared according to the EQUATOR research reporting guidelines, as listed below, and each submission should include a checklist (a reformatted version has been created for the journal) as a supplementary material. The relevant page/line and section/paragraph number in the manuscript should be stated for each item in the checklist. A statement should be included at the end of the “Introduction” to indicate which reporting checklist was followed (e.g., “We present the following article/case in accordance with the CONSORT reporting checklist.” ). The manuscript should also include a Reporting Checklist statement in the footnote (see the “3.7 Footnote”). Failure to do so will result in the manuscript being returned to the authors for amendment.
